Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 81401 - 81425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tretinoin	Approved Investigational Nutraceutical	EXTL3	2137	upregulated	Tretinoin results in increased expression of EXTL3 mRNA	8p21.1	A24453
Tretinoin	Approved Investigational Nutraceutical	EYA1	2138	downregulated	Tretinoin results in decreased expression of EYA1 mRNA	8q13.3	A24453
Tretinoin	Approved Investigational Nutraceutical	EYA1	2138	upregulated	Tretinoin results in increased expression of EYA1 mRNA	8q13.3	A24454
Tretinoin	Approved Investigational Nutraceutical	EYA2	2139	upregulated	Tretinoin results in increased expression of EYA2 mRNA	20q13.12	A24456
Tretinoin	Approved Investigational Nutraceutical	EYA4	2070	downregulated	Tretinoin results in decreased expression of EYA4 mRNA	6q23.2	A24454 A24453
Tretinoin	Approved Investigational Nutraceutical	EZH2	2146	downregulated	Tretinoin results in decreased expression of EZH2 mRNA	7q36.1	A24460
Tretinoin	Approved Investigational Nutraceutical	EZR	7430	downregulated	Tretinoin results in decreased expression of EZR mRNA	6q25.3	A24453
Tretinoin	Approved Investigational Nutraceutical	F11R	50848	upregulated	Tretinoin results in increased expression of F11R mRNA	1q23.3	A24454
Tretinoin	Approved Investigational Nutraceutical	F13A1	2162	downregulated	Tretinoin results in decreased expression of F13A1 mRNA	6p25.1	A24453
Tretinoin	Approved Investigational Nutraceutical	F2RL1	2150	upregulated	Tretinoin results in increased expression of F2RL1 mRNA	5q13.3	A24454
Tretinoin	Approved Investigational Nutraceutical	F2RL2	2151	upregulated	Tretinoin results in increased expression of F2RL2 mRNA	5q13.3	A24454
Tretinoin	Approved Investigational Nutraceutical	F3	2152	downregulated	Tretinoin results in decreased expression of F3 mRNA	1p21.3	A20812 A20813 A20814 A20815 A20816 A20817 A20818 A24529 A20711 A20819
Tretinoin	Approved Investigational Nutraceutical	F3	2152	upregulated	Tretinoin results in increased expression of F3 mRNA	1p21.3	A24454
Tretinoin	Approved Investigational Nutraceutical	FA2H	79152	downregulated	Tretinoin results in decreased expression of FA2H mRNA	16q23.1	A24456
Tretinoin	Approved Investigational Nutraceutical	FABP4	2167	upregulated	Tretinoin results in increased expression of FABP4 mRNA	8q21.13	A24464
Tretinoin	Approved Investigational Nutraceutical	FABP5	2171	upregulated	Tretinoin metabolite results in increased expression of FABP5 mRNA	8q21.13	A20508
Tretinoin	Approved Investigational Nutraceutical	FABP5	2171	downregulated	Tretinoin results in decreased expression of FABP5 mRNA	8q21.13	A20508 A24453
Tretinoin	Approved Investigational Nutraceutical	FABP7	2173	downregulated	Tretinoin results in decreased expression of FABP7 mRNA	6q22.31	A24454
Tretinoin	Approved Investigational Nutraceutical	FABP7	2173	upregulated	Tretinoin results in increased expression of FABP7 mRNA	6q22.31	A24469
Tretinoin	Approved Investigational Nutraceutical	FAIM	55179	upregulated	Tretinoin results in increased expression of FAIM mRNA	3q22.3	A24454
Tretinoin	Approved Investigational Nutraceutical	FAM105A	54491	upregulated	Tretinoin results in increased expression of FAM105A mRNA	5p15.2	A24453
Tretinoin	Approved Investigational Nutraceutical	FAM107B	83641	upregulated	Tretinoin results in increased expression of FAM107B mRNA	10p13	A24456
Tretinoin	Approved Investigational Nutraceutical	FAM110B	90362	upregulated	Tretinoin results in increased expression of FAM110B mRNA	8q12.1	A24454
Tretinoin	Approved Investigational Nutraceutical	FAM110C	642273	upregulated	Tretinoin results in increased expression of FAM110C mRNA	2p25.3	A24454
Tretinoin	Approved Investigational Nutraceutical	FAM111A	63901	upregulated	Tretinoin results in increased expression of FAM111A mRNA	11q12.1	A24453

Displaying entries 81401 - 81425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability